We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
104 hedge funds and large institutions have $363M invested in Amphastar Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 41 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
1% less capital invested
Capital invested by funds: $365M → $363M (-$2.58M)
0.78% less ownership
Funds ownership: 44.7% → 43.92% (-0.78%)
4% less funds holding
Funds holding: 108 → 104 (-4)
24% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 41
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Holders
104
Holders Change
-4
Holders Change %
-3.7%
% of All Funds
2.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
31
Reduced
41
Closed
12
Calls
–
Puts
$8K
Net Calls
-$8K
Net Calls Change
+$8K
Top Buyers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.72M |
| 2 |
BlackRock
New York
|
+$1.93M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$1.78M |
| 4 |
ACM
Argent Capital Management
St Louis,
Missouri
|
+$1.01M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$709K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.13M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.65M |
| 4 |
Morgan Stanley
New York
|
-$1.08M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$989K |
